H-CPRECES-OH

Ref. 3D-PP44527

Información del producto

• Nombre: H-CPRECES-OH
• Sinónimos: NH2-Cys-Pro-Arg-Glu-Cys-Glu-Ser-OH

Descripción

Peptide H-CPRECES-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CPRECES-OH include the following: Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis YY Guan, X Luan , JR Xu , YR Liu, Q Lu, C Wang, HJ Liu - Biomaterials, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961213015111 Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation S Adityan, M Tran , C Bhavsar , SY Wu - Journal of controlled release, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365920304569 Nanovesicles and its use for nucleic acid delivery MF Segura , S Gallego, J Sanchez de Toledo - 2020 - digital.csic.eshttps://digital.csic.es/handle/10261/243443 Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma M Loi, S Marchiaca² , P Becherini, D Di Paolo - Journal of controlled , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365910002208 The use of alternative strategies for enhanced nanoparticle delivery to solid tumors M Izci, C Maksoudian, BB Manshian - Chemical , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.chemrev.0c00779 Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease J Lahdenranta, RL Sidman, R Pasqualini - The FASEB , 2007 - Wiley Online Libraryhttps://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.07-8273com Patent application title: TARGETED DELIVERY TO HUMAN DISEASES AND DISORDERS Inventors: Joao Nuno Sereno De Almeida Moreira (Coimbra, PT) IPC Class, A USPC - 2014 - patentsencyclopedia.comhttps://www.patentsencyclopedia.com/app/20140004042 Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma F Pastorino, C Brignole , M Loi, D Di Paolo - Frontiers in , 2013 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2013.00190/full Overcoming biological barriers in neuroblastoma therapy: the vascular targeting approach with liposomal drug nanocarriers F Pastorino, C Brignole , D Di Paolo, P Perri , F Curnis - Small, 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/smll.201804591 Pericyte-targeting drug delivery and tissue engineering E Kang, JW Shin - International Journal of Nanomedicine, 2016 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S105274 TARGETED NANOMEDICINES FOR APPLICATIONS IN PRECLINICAL CANCER MODELS АДЛ ÐÐÐÐşÐŞÐ Ð•ÐŞÐÐ ÐÐ¢ÐşÐ’ - Bulletin of Russian State Medical - scholar.archive.orghttps://scholar.archive.org/work/lfxsgi5nbzbpjczje3o3csqd7m/access/wayback/https://vestnikrgmu.ru/files/issues/2018/2018-6_en.pdf#page=5 Tumor Blood Vessels and Tumor Endothelial Cells D Ribatti , D Ribatti - The Role of Microenvironment in the Control of Tumor , 2016 - Springerhttps://link.springer.com/chapter/10.1007/978-3-319-27820-9_2 The structure of the vascular network of tumors D Ribatti , B Nico , E Crivellato, A Vacca - Cancer letters, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304383506004162 Genes and Proteins of Myeloma Endothelial Cells to Search Specific Targets of the Tumor Vasculature D Ribatti , A Vacca - Advances in Biology and Therapy of Multiple Myeloma , 2012 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4614-4666-8_13 The role of microenvironment in the control of tumor angiogenesis D Ribatti - 2016 - Springerhttps://link.springer.com/content/pdf/10.1007/978-3-319-27820-9.pdf OSTP as a novel peptide specifically targeting human ovarian cancer C Yang, X He, X Liu, Z Tang - Oncology , 2015 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/or.2015.4066 A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging A Hajitou, DC Lev, JAF Hannay - Proceedings of the , 2008 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0712184105

• Marca: Biosynth